Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | BCL3 |
| Upstream (Parents) |
|---|
| (<<) ARSA → BCL3 |
| (<<) BCAR1 → BCL3 |
| (<<) CASP7 → BCL3 |
| (<<) CDC42EP1 → BCL3 |
| (<<) CDC42EP2 → BCL3 |
| (<<) CISH → BCL3 |
| (<<) CREB3L1 → BCL3 |
| (<<) CSNK1D → BCL3 |
| (<<) CSNK1E → BCL3 |
| (<<) EFHD2 → BCL3 |
| (<<) EHD1 → BCL3 |
| (<<) EPN3 → BCL3 |
| (<<) GNA15 → BCL3 |
| (<<) GRN → BCL3 |
| (<<) ISG20 → BCL3 |
| (<<) JUNB → BCL3 |
| (<<) KIAA1949 → BCL3 |
| (<<) KYNU → BCL3 |
| (<<) LOC92249 → BCL3 |
| (<<) MAP3K11 → BCL3 |
| (<<) MAP3K7 → BCL3 |
| (<<) MOBKL2C → BCL3 |
| (<<) NFKBIZ → BCL3 |
| (<<) PRKACA → BCL3 |
| (<<) PRR5 → BCL3 |
| (<<) PTK2B → BCL3 |
| (<<) RARA → BCL3 |
| (<<) RXRA → BCL3 |
| (<<) TK2 → BCL3 |
| (<<) TMEM175 → BCL3 |
| (<<) VPS37B → BCL3 |
| Downstream (Children) |
|---|
| BCL3 → CAPRIN2 (>>) |
| BCL3 → CEP170 (>>) |
| BCL3 → DKFZP434I0714 (>>) |
| BCL3 → FUT2 (>>) |
| BCL3 → GYS1 (>>) |
| BCL3 → IQSEC2 (>>) |
| BCL3 → ITGB4 (>>) |
| BCL3 → ITGB6 (>>) |
| BCL3 → KCNG1 (>>) |
| BCL3 → LDLR (>>) |
| BCL3 → MST1R (>>) |
| BCL3 → NCOR1 (>>) |
| BCL3 → PITPNC1 (>>) |
| BCL3 → PPP3CA (>>) |
| BCL3 → RPA4 (>>) |
| BCL3 → RRP15 (>>) |
| BCL3 → SLC5A1 (>>) |
| BCL3 → SPINK5 (>>) |
| BCL3 → STAT6 (>>) |
| BCL3 → THRB (>>) |
